Literature DB >> 16837850

Serine racemase protein expression in cortex and hippocampus in schizophrenia.

Amy E Steffek1, Vahram Haroutunian, James H Meador-Woodruff.   

Abstract

Evidence of glutamatergic dysfunction in schizophrenia associated with the N-methyl-D-aspartate receptor has historically demonstrated changes primarily attributable to neurons. We propose an astrocytic component to N-methyl-D-aspartate receptor dysfunction in this illness. We studied the expression of serine racemase, an astrocytic enzyme which synthesizes the N-methyl-D-aspartate receptor coagonist D-serine, using Western blot analysis in postmortem hippocampus and cortex in schizophrenia and a comparison group. We found increased expression in the hippocampus in schizophrenia. This is the first study to demonstrate alterations in schizophrenia of an astrocytic enzyme responsible for synthesizing a neuromodulator, and further evidence that astrocytes may play a direct role in N-methyl-D-aspartate receptor dysfunction in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837850     DOI: 10.1097/01.wnr.0000230512.01339.72

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  14 in total

Review 1.  Glial cells in schizophrenia: a unified hypothesis.

Authors:  Andrea G Dietz; Steven A Goldman; Maiken Nedergaard
Journal:  Lancet Psychiatry       Date:  2019-11-06       Impact factor: 27.083

Review 2.  The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.

Authors:  Wei Hu; Matthew L MacDonald; Daniel E Elswick; Robert A Sweet
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

3.  Effects of low-dose D-serine on recognition and working memory in mice.

Authors:  Patricia Bado; Caroline Madeira; Charles Vargas-Lopes; Thiago C Moulin; Ana Paula Wasilewska-Sampaio; Luise Maretti; Ricardo V de Oliveira; Olavo B Amaral; Rogério Panizzutti
Journal:  Psychopharmacology (Berl)       Date:  2011-05-10       Impact factor: 4.530

Review 4.  Metabolism of the neuromodulator D-serine.

Authors:  Loredano Pollegioni; Silvia Sacchi
Journal:  Cell Mol Life Sci       Date:  2010-03-02       Impact factor: 9.261

Review 5.  Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia.

Authors:  Meng Xia; Sofya Abazyan; Yan Jouroukhin; Mikhail Pletnikov
Journal:  Schizophr Res       Date:  2014-11-20       Impact factor: 4.939

6.  In vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophrenia.

Authors:  Matthew D Puhl; Dionyssios Mintzopoulos; J Eric Jensen; Timothy E Gillis; Glenn T Konopaske; Marc J Kaufman; Joseph T Coyle
Journal:  Neurobiol Dis       Date:  2014-10-23       Impact factor: 5.996

Review 7.  The neurobiology of D-amino acid oxidase and its involvement in schizophrenia.

Authors:  L Verrall; P W J Burnet; J F Betts; P J Harrison
Journal:  Mol Psychiatry       Date:  2009-09-29       Impact factor: 15.992

Review 8.  Schizophrenia: Evidence implicating hippocampal GluN2B protein and REST epigenetics in psychosis pathophysiology.

Authors:  C A Tamminga; R S Zukin
Journal:  Neuroscience       Date:  2015-07-23       Impact factor: 3.590

9.  Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis.

Authors:  Gursharan Chana; Chad A Bousman; Tammie T Money; Andrew Gibbons; Piers Gillett; Brian Dean; Ian P Everall
Journal:  Front Cell Neurosci       Date:  2013-06-26       Impact factor: 5.505

10.  Association between SNPs and gene expression in multiple regions of the human brain.

Authors:  S Kim; H Cho; D Lee; M J Webster
Journal:  Transl Psychiatry       Date:  2012-05-08       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.